LINC 2019 Symposium

Watch the recording and download IMPERIAL and COMPARE data sheets now.
Receive the latest news of Drug Eluting Technologies. Sign up

Download data sheets

Learn more about the statistically significant difference in TLR Eluvia demonstrated in the IMPERIAL Diabetic Subgroup Analysis.
Learn more about the similar patency rate of Ranger DCB vs In.Pact DCB with COMPARE-1 2 year data.
 

LINC 2019 Symposium “Data supported solutions for peripheral arterial disease intervention.” Moderators: D. Scheinert, Y. Gouëffic; Panel: K. Katsanos, C. del Giudice, S. Müller-Hülsbeck


Intro & Learning objectives

Y. Goueffic

Video length: 01:04


 

Benchmarking Ranger drug-coated balloon data in SFA treatment.

D. Scheinert

Ranger Clinical program and what we can expect from it in the future. Latest results of COMPARE-I 2 year data.

Video length: 13:18


 

Downstaging complexity for a DCB strategy in claudicants.

K. Katsanos

What are the advantages of using atherectomy?
Review of  current clinical program around Jetstream.

Video length: 14:23


 

Gauging performance in below-the-knee intervention.

C. del Giudice

Drug eluting technologies in BKT segment. Current treatment options and what is next to come.

Video length: 08:55


 

LINC 2019 Symposium – Live case

Live case from University Hospital of Leipzig.

Operators: M. Ulrich, D. Bräunlich.
Clinical data: Distal SFA Occlusion.

  • 76 years old male
  • PAOD Rutherford class 4, rest pain and severe claudication right, ABI 0.4
  • Renal impairment grade 2

Risk factors: Arterial hypertension, hyperlipidemia, diabetes mellitus type 2

Video length: 20:42


 

Raising the bar with Eluvia drug-eluting stent data.

S. Mueller Huelsbeck

Eluvia clinical program and what we can expect from it in the future. Latest results of IMPERIAL diabetics subgroup.

Video length: 14:09


Receive the latest news of Drug Eluting Technologies. Sign up
Top